Search Results - yuan hong

1 Results

Sort By:

Fc receptor targeted and virus-like particle (VLP) based tripartite chimeric vaccine technology

TECH ID 2012-025 Title: Tripartitie Polypeptide Vaccine Vector Current State of the Art: Although traditionally viewed as an anti-infectious preventive measure, vaccine use has expanded to treating non-infectious diseases including cancer. Provenge (Dendreon) is currently the only FDA approved therapeutic vaccine at approximately $95,000 per treatm...

Published: 8/13/2019 | Inventor(s): Yukai He, David Munn, Yuan Hong

Keywords(s):

Category(s): Therapeutics